Skip to main content

Infectious Diseases

Featured Article

Quiz
09/22/2023
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all children in the US become infected with RSV?
At what age do nearly all...
09/22/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
News
02/25/2021
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate homebound older adults, but the efforts are slow and spotty.
Health organizations have begun...
02/25/2021
Pharmacy Learning Network
Interview
02/24/2021
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder, Luma Health, identifies what is lacking in vaccine delivery and operations, and offers tips for health administrators and health systems that are looking to improve their vaccine rollout.
Adnan Iqbal, CEO and co-founder,...
02/24/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network

Newsfeed

News
01/13/2020
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated the influenza vaccine’s effectiveness against laboratory-confirmed influenza-associated hospitalizations among older adults with COPD.
Authors of a new study evaluated...
01/13/2020
Pharmacy Learning Network
News
11/25/2019
Amanda Balbi
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to influenza vaccination can help the development of interventions to reduce influenza vaccine hesitancy, increase vaccination, and reduce influenza burden,” researchers wrote.
“Understanding barriers to...
11/25/2019
Pharmacy Learning Network
News
10/28/2019
Amanda Balbi
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
09/11/2019
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society has released a new clinical practice guideline on laboratory testing for the diagnosis of fungal infections in pulmonary and critical care practice.
The American Thoracic Society...
09/11/2019
Pharmacy Learning Network
PharmLaw
06/24/2026
Hannah Musick
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care...
06/24/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
PharmLaw
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
PharmLaw
06/11/2026
Hannah Musick
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli...
06/11/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
01/19/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the ongoing evolution of the SARS-CoV-2 virus, Dr Jennings reviews efficacy data on 2 non-antiviral drugs for the treatment of patients with COVID-19.
In light of new research and the...
01/19/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
11/23/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the Omicron subvariants BQ.1 and BQ.1.1.
Dr Jennings shares new guidance...
11/23/2022
Pharmacy Learning Network
Videos
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Interview
04/19/2021
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed...
Sudeb Dalai, MD, PhD, senior...
04/19/2021
Pharmacy Learning Network
Talking Therapeutics
03/03/2021
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
Headshot of Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, on a dark blue background
Podcasts
02/03/2021
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson & Johnson COVID-19 vaccines, discusses how these vaccines...
Michael Ganio, PharmD, senior...
02/03/2021
Pharmacy Learning Network
Headshot of Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, on a dark blue background
Podcasts
01/21/2021
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses,...
Valerie Montgomery Rice, MD,...
01/21/2021
Pharmacy Learning Network
Commentary
07/20/2020
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through this challenging time in history and emerge stronger, healthier, wiser and hopefully even more grateful each day for the gift of life,” Yvette C Terrie, BS Pharm, RPh, expresses.
“Together we will get through...
07/20/2020
Pharmacy Learning Network